Related Experiment Video
Updated: Jan 13, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Hypertension guidelines need to be patient oriented
Nayanatara Nadeesha Tantirige1, Joanna M Gray1, Ian B Wilkinson2
1Cambridge University Hospitals NHS Foundation Trust, Cambridge.
Insights
Personalised hypertension treatment improves blood pressure control by considering individual factors like genetics and ethnicity. Future guidelines should incorporate these personalised approaches for better patient outcomes.
Area of Science:
- Cardiology
- Pharmacogenomics
- Clinical Hypertension
Background:
- Hypertension management traditionally uses a one-size-fits-all approach.
- Growing evidence suggests personalized treatment improves blood pressure control.
- Inter-individual variability in treatment response necessitates tailored strategies.
Purpose of the Study:
- To review current evidence supporting individualized hypertension treatment.
- To explore the application of personalized medicine in future hypertension guidelines.
- To examine variability in blood pressure control and treatment response.
Main Methods:
- Literature review of recent studies on hypertension treatment personalization.
- Analysis of factors influencing inter-individual variability in drug response.
- Examination of genetic data, including genome-wide association studies (GWAS) and polygenic risk scores (PRS).
Main Results:
- Significant inter-individual variability exists in responses to antihypertensive medications.
- Factors like ethnicity, sex, age, BMI, and genetics influence blood pressure and cardiovascular risk.
- Emerging genetic data and polygenic risk scores show promise for targeted pharmacotherapy.
Conclusions:
- Personalized hypertension care is a rapidly developing field.
- Clinical guidelines need refinement to better address individual differences in blood pressure and treatment response.
- Tailoring hypertension treatment based on individual patient characteristics is crucial for optimal outcomes.
Purpose Of Review:
There is growing evidence that personalisation of hypertension treatment leads to better blood pressure control. This review will explore current evidence for individualised treatment of hypertension, and application of this in future guidelines.
Recent Findings:
Recent studies demonstrate considerable inter-individual variability in responses to specific antihypertensives. Factors such as ethnicity, sex, age, BMI and genetics contribute to differences in blood pressure and cardiovascular risk. There is emerging ethnicity data that may help to support targeted pharmacotherapy. Advances in genetics, particularly through large-scale genome-wide association studies (GWAS), have given us insight into individual genetic determinants of blood pressure. The development of polygenic risk scores (PRS) also show promise for future precision-guided treatment. This review will examine both intra-individual and inter-individual variability in blood pressure control and treatment response using evidence to date.
Summary:
Personalised hypertension care is an evolving field. Our review highlights the importance of refining clinical guidelines to better account for individual differences in blood pressure and treatment response.
Related Concept Videos
Hypertension V: Nursing Management
Hypertension I: Introduction
Hypertension IV: Drug Therapy and Lifestyle Modifications
Pre-Procedural Guidelines for Assessing Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure

